Laman Jon D, Kooistra Susanne M, Clausen Björn E
Section Medical Physiology, Department of Neuroscience, University of Groningen, University Medical Center Groningen, Antonius Deusinglaan 1, NL-9713 AV, Groningen, The Netherlands.
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz, Obere Zahlbacher Straße 67, Mainz, D-55131, Germany.
Methods Mol Biol. 2017;1559:1-17. doi: 10.1007/978-1-4939-6786-5_1.
In light of an enhanced awareness of ethical questions and ever increasing costs when working with animals in biomedical research, there is a dedicated and sometimes fierce debate concerning the (lack of) reproducibility of animal models and their relevance for human inflammatory diseases. Despite evident advancements in searching for alternatives, that is, replacing, reducing, and refining animal experiments-the three R's of Russel and Burch (1959)-understanding the complex interactions of the cells of the immune system, the nervous system and the affected tissue/organ during inflammation critically relies on in vivo models. Consequently, scientific advancement and ultimately novel therapeutic interventions depend on improving the reproducibility of animal inflammation models. As a prelude to the remaining hands-on protocols described in this volume, here, we summarize potential pitfalls of preclinical animal research and provide resources and background reading on how to avoid them.
鉴于在生物医学研究中使用动物时,人们对伦理问题的认识不断提高,且成本不断增加,关于动物模型的(缺乏)可重复性及其与人类炎症性疾病的相关性存在一场专门的、有时甚至激烈的辩论。尽管在寻找替代方法方面取得了明显进展,即替代、减少和优化动物实验——罗素和伯奇(1959年)提出的三个R原则——但要理解免疫系统、神经系统和受影响组织/器官的细胞在炎症过程中的复杂相互作用,关键仍依赖于体内模型。因此,科学进步以及最终的新型治疗干预措施取决于提高动物炎症模型的可重复性。作为本卷其余实际操作方案的前奏,在此我们总结临床前动物研究的潜在陷阱,并提供有关如何避免这些陷阱的资源和背景阅读材料。